| 000 | 01811 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516192121.0 | ||
| 264 | 0 | _c20141001 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1598-6357 | ||
| 024 | 7 |
_a10.3346/jkms.2014.29.1.53 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHwang, Hee Sang | |
| 245 | 0 | 0 |
_aIntestinal diffuse large B-cell lymphoma: an evaluation of different staging systems. _h[electronic resource] |
| 260 |
_bJournal of Korean medical science _cJan 2014 |
||
| 300 |
_a53-60 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aIntestinal Neoplasms _xclassification |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xclassification |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Staging _xmethods |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSurvival |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aYoon, Dok Hyun | |
| 700 | 1 | _aSuh, Cheolwon | |
| 700 | 1 | _aPark, Chan-Sik | |
| 700 | 1 | _aHuh, Jooryung | |
| 773 | 0 |
_tJournal of Korean medical science _gvol. 29 _gno. 1 _gp. 53-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3346/jkms.2014.29.1.53 _zAvailable from publisher's website |
| 999 |
_c23455955 _d23455955 |
||